RHUMBLINE ADVISERS - AVEO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$113,000
-48.9%
138,373
+0.1%
0.00%
Q4 2018$221,000
-27.3%
138,271
+50.4%
0.00%
-100.0%
Q3 2018$304,000
+45.5%
91,964
-0.7%
0.00%
Q2 2018$209,000
+99.0%
92,635
+32.1%
0.00%
Q1 2014$105,000
-21.6%
70,111
-3.5%
0.00%
Q4 2013$134,000
-16.2%
72,641
-6.0%
0.00%
Q3 2013$160,000
-17.5%
77,241
-0.6%
0.00%
-100.0%
Q2 2013$194,00077,7140.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Deer VI & Co. LLC 675,242$1,884,000100.00%
Prosight Management, LP 1,057,690$2,951,0002.17%
NEA Management Company, LLC 16,362,694$45,652,0001.89%
EMORY UNIVERSITY 602,883$1,682,0001.44%
New Leaf Venture Partners, L.L.C. 964,520$2,691,0001.26%
RA Capital Management 5,062,759$14,125,0001.18%
Avoro Capital Advisors LLC 4,006,893$11,179,0000.72%
683 Capital Management, LLC 2,500,000$6,975,0000.59%
X-Square Capital, LLC 199,345$557,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 1,300,000$3,627,0000.43%
View complete list of AVEO PHARMACEUTICALS INC shareholders